NCT05830279View on ClinicalTrials.gov

Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer

RecruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Nausea With Vomiting Chemotherapy-InducedDepression, ReactiveCancer Pain
Interventions
GENETIC

Pharmacogenetic testing

Genotyping for CYP2D6 and CYP2C19

OTHER

Drug-Drug interaction analysis

Evaluating potential drug interactions with CYP2D6, CYP2C9 and CYP3A4 inhibitors and inducers using the Medical Letter.

Trial Locations (1)

N6C 2R5

RECRUITING

Lawson Health Research Institute, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER